Medindia

X

Orchid Gets USFDA Nod for Cephalexin

by Medindia Content Team on  July 12, 2006 at 8:36 AM Drug News   - G J E 4
Orchid Gets USFDA Nod for Cephalexin
Orchid Chemicals & Pharmaceuticals Ltd today said it has received approval from the USFDA for its ANDA (Abbreviated New Drug Application) of Cephalexin oral suspension.
Advertisement

Cephalexin, an off-patent molecule, forms part of Orchid Chemicals' distribution alliance with US generic pharma major Par Pharmaceuticals Inc, it informed the Bombay Stock Exchange.

Advertisement
Orchid added that its Cephalexin capsules are already marketed in the US through partnership with Par Pharmaceuticals and following this approval, the number of dosage forms, oral solids and injections distributed by it in the US now stands at 12.

The company's shares were trading at Rs 185.30, up 1.12 per cent at the BSE.

Source:PTI News
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All